
Melanoma



April 17, 2023
Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma
The ASCO Post

January 05, 2024
Rare T Cells May Help Predict Immunotherapy Response in Patients With Skin Cancer
The ASCO Post

Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.

April 29, 2024
Adjuvant mRNA-Based Personalized Therapy Plus Immunotherapy in High-Risk Resected Melanoma
Conexiant



Advertisement
Recommendations
Advertisement